심전도(ECG) : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the electrocardiograph (ECG) market size is projected to be USD 7.81 billion in 2025, USD 8.43 billion in 2026, and reach USD 12.33 billion by 2031, growing at a CAGR of 7.92% from 2026 to 2031.

This report is Segmented by Product Type (Resting ECG Systems, Stress ECG Systems, Holter Monitors, Event Recorders, and More), Lead Type (Single-Lead, 3-6 Lead, and More), End User (Hospitals & Clinics, Ambulatory Surgical Centers, and More), Technology (Analog, Digital/Cloud-connected), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Electrocardiograph (ECG) Market Trends and Insights

Rising Cardiovascular-Disease Prevalence

Ischemic heart disease and stroke caused 17.9 million deaths in 2024 and are projected to reach 23 million by 2030, raising demand for early detection worldwide . India's national program screened 150 million adults in 2025 with battery-operated devices that travel to rural clinics. Employers and payers recognize the USD 1.1 trillion annual economic burden, so reimbursement now favors longitudinal ECG monitoring instead of episodic testing. The result is a broader install base of portable systems in primary care and community centers.

Rapid Adoption of AI-Enabled ECG Devices

Fourteen AI-ECG algorithms cleared by the FDA in 2025 reflect regulator confidence in machine learning interpretation. Mayo Clinic's platform cut time-to-diagnosis for myocardial infarction by 18 minutes in emergency departments that adopted it in 2025. Draft guidance on algorithmic fairness issued in September 2025 now requires validation across sex, race, and age, likely delaying launches yet building clinician trust. Urban hospitals are first movers because they have cloud infrastructure, while rural sites rely on manual reads. Vendors reply by embedding edge processors that run algorithms offline.

Other drivers and restraints analyzed in the detailed report include:

1. Accelerating Shift to Home & Remote Cardiac Monitoring
2. Government-Funded Mass Screening Programs
3. Fragmented Reimbursement in Emerging Markets
4. Shortage of ECG-Trained Technicians

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Resting systems secured 45.87% of revenue in 2025, but wearables and patches posted the highest 8.11% CAGR as new CPT codes make remote monitoring financially attractive. Holter monitors lose share to 14-day patches such as Zio, which grew prescriptions 38% in 2025. Stress systems confront competition from coronary CT angiography because payers perceive a higher diagnostic yield. Software adds recurring revenue; Philips' cloud platform integrates with Epic and Cerner using FHIR, reaching gross margins above 70%.

The wearables wave is reshaping procurement: consumer-electronics giants supply single-lead devices at minimal cost, pushing medical vendors to bundle multi-lead fidelity and analytics. The Electrocardiograph (ECG) market size for software is projected to expand faster than hardware due to the margin advantages. Hospitals retain cart-based resting systems for acute triage, but outpatients and home settings increasingly favor lightweight patches and watches.

Twelve-lead models maintained 49.98% Electrocardiograph (ECG) market share in 2025 because guidelines still treat them as the diagnostic gold standard. Meanwhile, 3-6-lead devices rise at an 8.43% CAGR to serve ambulatory centers prioritizing rapid setup and portability. Single-lead wearables sold 45 million units in 2025; however, their limited spatial resolution yields higher false-positive rates, taxing cardiology referral systems.

Advanced 15/18-lead systems stay confined to academic centers: GE's MAC 2000 costs more than USD 25,000 and needs expert placement. As payers do not reimburse extra leads, penetration remains niche. The Electrocardiograph (ECG) market size for 3-6-lead devices should widen as outpatient procedures grow, narrowing the gap with 12-lead carts.

Complete Report Scope:

• By Product Type
  • Resting ECG Systems
  • Stress ECG Systems
  • Holter Monitors
  • Event Recorders
  • Wearable / Patch ECG Devices
  • ECG Management Software
• By Lead Type
  • Single-Lead ECG
  • 3-6 Lead ECG
  • 12-Lead ECG
  • Others
• By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Home Settings / Remote Patients
  • Diagnostic Labs & Cardiac Centers
• By Technology
  • Analog ECG Devices
  • Digital / Cloud-connected ECG Devices
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

Asia-Pacific records the fastest 8.81% CAGR through 2031 on the back of mass-screening mandates in China and India, local manufacturing by Mindray and EDAN, and smartphone penetration that supports Bluetooth-paired single-lead devices. Japan's 28.4% senior population fuels home monitoring, while South Korea covers 30-day monitoring for atrial fibrillation. Australia halved software-approval timelines, enticing venture-backed entrants.

North America held 45.3% revenue in 2025, but growth moderates as hospital penetration nears saturation. CPT 93264 nevertheless channels fresh volume to wearable vendors. Canada trails because provincial budgets tighten, and Mexico's federal procurement lingers in negotiation. Europe rebounded after MDR bottlenecks eased; Germany now funds four virtual cardiology visits annually for heart-failure patients.

The Middle East & Africa account for a notable share of revenue; the UAE registry requirement anchors future demand. South Africa purchased 5,000 portable units in 2025 to mitigate power-outage disruptions. South America wrestles with currency volatility; Brazil's real depreciation raised import costs, steering buyers to lower-priced models.

1. Abbott Laboratories
2. AliveCor
3. Apple
4. BIOTRONIK
5. BPL
6. Cardiac Insight Inc.
7. CardioComm Solutions
8. Compumed Inc.
9. EDAN Instruments
10. Fukuda Denshi Co.
11. GE Healthcare
12. Baxter
13. iRhythm Technologies
14. Medtronic
15. Mindray
16. Nihon Kohden
17. OMRON
18. OSI Systems (Spacelabs)
19. Koninklijke Philips
20. Schiller
21. Shenzhen Creative

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Cardiovascular-Disease Prevalence
  • 4.2.2 Rapid Adoption of AI-Enabled ECG Devices
  • 4.2.3 Accelerating Shift to Home & Remote Cardiac Monitoring
  • 4.2.4 Government-Funded Mass Screening Programs
  • 4.2.5 Edge-Computing ECG Analytics in Emergency Vehicles
  • 4.2.6 Sub-USD 99 Embedded Single-Lead ECG Modules for OEMS
• 4.3 Market Restraints
  • 4.3.1 Fragmented Reimbursement in Emerging Markets
  • 4.3.2 Shortage of ECG-Trained Technicians
  • 4.3.3 Cyber-Security & Data-Privacy Risks in Cloud ECG Platforms
  • 4.3.4 Algorithm Bias Impacting Accuracy for Women & Dark-Skin Populations
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Resting ECG Systems
  • 5.1.2 Stress ECG Systems
  • 5.1.3 Holter Monitors
  • 5.1.4 Event Recorders
  • 5.1.5 Wearable / Patch ECG Devices
  • 5.1.6 ECG Management Software
• 5.2 By Lead Type
  • 5.2.1 Single-Lead ECG
  • 5.2.2 3-6 Lead ECG
  • 5.2.3 12-Lead ECG
  • 5.2.4 Others
• 5.3 By End User
  • 5.3.1 Hospitals & Clinics
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Home Settings / Remote Patients
  • 5.3.4 Diagnostic Labs & Cardiac Centers
• 5.4 By Technology
  • 5.4.1 Analog ECG Devices
  • 5.4.2 Digital / Cloud-connected ECG Devices
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Abbott
  • 6.3.2 AliveCor Inc.
  • 6.3.3 Apple Inc.
  • 6.3.4 Biotronik SE & Co. KG
  • 6.3.5 BPL Medical Technologies
  • 6.3.6 Cardiac Insight Inc.
  • 6.3.7 CardioComm Solutions
  • 6.3.8 Compumed Inc.
  • 6.3.9 EDAN Instruments
  • 6.3.10 Fukuda Denshi Co.
  • 6.3.11 GE Healthcare
  • 6.3.12 Baxter International Inc
  • 6.3.13 iRhythm Technologies
  • 6.3.14 Medtronic plc
  • 6.3.15 Mindray Medical International
  • 6.3.16 Nihon Kohden Corporation
  • 6.3.17 Omron Healthcare
  • 6.3.18 OSI Systems (Spacelabs)
  • 6.3.19 Philips Healthcare
  • 6.3.20 Schiller AG
  • 6.3.21 Shenzhen Creative

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment